Ethnobotanical Leaflets 12: 643-646. 2008.
Relationship Between the
ACE Gene Polymorphism and Angiographic Coronary Artery Disease
*Indra, M and P. Annapoorani Department of Biochemistry, *E-mail:
indhu_darsini@yahoo.co.in Issued Abstract The relationship
between angiotensin-converting enzyme (ACE) gene
polymorphism and several cardiovascular diseases such as myocardial
infarction (MI) and its prognosis is controversial. Clinical evolution, ACE
levels, and ACE polymorphism were studied. A control group of 20 valvular patients with normal angiography was
established. Angiographic study was done in 50 patients. Our
studies reveal that CAD patients with DD genotype of 287 bp
ACE gene which is located in the 6th chromosome are under great
risk then the DI genotype and II genotype patients of virudhunager,
it is as recent with global report .The DD genotype was more frequent in the
CAD patient compare to the control the relative risk for DD genotype was
high. Key words: ACE gene insertion, deletion
polymorphism, ACE activity, blood pressure, coronary artery disease. Introduction The
conversion of angiotensin I into angiotensin II .Angiotensin II has a variety of
function but for simply say that directly increases blood pressure by
constricting arteries and indirectly raises blood volume, coronary artery
disease (CAD) is a multifactorial disease caused by
various genetic and environmental factors involved in the atherosclerosis and
thrombin complication .inflamations plays a key
role in susceptibility to coronary atherosclerosis. The genomic MATERIALS Study population: Our case-control study population consisted of 50 CAD patients with ages ranging from (20 -50) .Angiotensin converting enzyme was identified in patients who underwent coronary angiography between Jan 2006- April 2006. . With use of a standardized questionnaire, the medical history of patients and medications used at the time of the coronary angiography were carefully recorded. Control groups consisted of subjects free from CAD, based on physical examination, history of cardiovascular disease and electrocardiogram. The presence of hypertension, diabetes mellitus, and smoking status were exclusion criteria from the control group. Determination of ACE D/D polymorphism: Genomic
RESULTS The DD genotype was more frequent
in the CAD patients and they are the more risk group then DI/II allele. The baseline characteristics of the
study groups are presented .The age and gender distributions of patients with
CAD and controls were not similar. To prevent affection of this bias on our
study we selected control patients as free of coronary risk factors (smoking,
hypertension, diabetes). But despite we minimize these bias, age and gender
differences are remained to be the limitations of our study. Significant
differences were noted between study groups in respect of total cholesterol,
triglycerides and Cardiovascular disease is the major cause of morbidity and
mortality in virudhunagar district. It is well
known that the etiology of this devastating disorder involves both genetic
and environmental factors. Sequence variants of the components of the rennin angiotensin-aldosterone system and the kallikrein-kinin system are suggested to have significant
influences on cardiovascular homeostasis. Thus, the ACE gene has been recognized
as a top candidate gene for cardiovascular research. While a number of
studies have implicated the role of the ACE polymorphism in cardiac
disorders, such as myocardial infarction CAD, left ventricular hypertrophy and
hypertension others have argued that it may be associated with increase in
plasma ACE activity without being a risk factor for coronary heart disease .
These inconsistent results may depend on the gender differences and ethnic
traits of the individual populations reported significant association of
ACE gene DD polymorphism and CAD . In this study, we analyzed the association
between polymorphism
in the ACE gene and CAD relation in individuals. The DD genotype was more frequent in the CAD
patient compare to the control the relative risk for DD genotype was high. REFERENCES Akar N, Aras O, Omurlu K, Cin S. Deletion
polymorphism at the angiotensin converting enzyme
gene in Turkish patients with coronary artery disease. Scand J Clin Lab Invest 1998; 58: 491-5. Barley J, Blackwood A, Carter ND, et al. Angiotensin converting enzyme insertion/deletion
polymorphism: association with ethnic origin. J Hypertens.
1994; 12: Bohn M, Berge KE, Bakken
A, Erikssen J, Berg K. Insertion/deletion (I/D)
polymorphism at the locus for angiotensin
I-converting enzyme and parental history of myocardial infarction. Clin Genet 1993; 44: 292-301. Cambien F, Poirier O, Lecerf L,
et al. Deletion polymorphism in the gene for angiotensin-converting
enzyme is a potent risk factor for myocardial infarction. Nature 1992;
359: 641-4. Campbell-Boswell M, Robertson AL. Effects of angiotensin II and vasopressin on human smooth muscle
cells in vitro. Exp Mol Pathol. 1981; 35:
265-76. Converting enzyme activity but not with increased
risk for myocardial infarction and coronary artery disease.Ann
Intern Med 1996; 12: 519-25. Fogarty DG, Maxwell AP, Doherty CC, Hughes AE, Nevine NC. ACE gene typing. Lancet 1994; 343: 851.
Harrap SP, Davidson HR, Connor JM, et al. The angiotensin I-converting enzyme gene and predisposition
to high blood pressure. Hypertension 1993; 21: 455- 60. Isbir T, Yilmaz H, Agachan B, Aydin M, Isbir CS. Association between angiotensin
converting enzyme gene polymorphism and coronary artery disease. IUBMB Life 1999;
48: 205-7. Iwai N, Ohmichi N,
Nakamura Y, Kinoshita M. DD genotype of the angiotensin-converting
enzyme gene is a risk factor for left ventricular hypertrophy. Circulation.
1994; 90: 2622-8. Kupari M, Perola M, Koskinen P, Virolainen J, Karhunen PJ. Left ventricular size, mass, and function in
relation to angiotensin-converting enzyme gene
polymorphism in humans. Am J Physiol.
1994; 267: 1107- 11. Lindpainter K, Pfeffer MA, Kreutz R, et al. A prospective evaluation of angiotensin-converting-enzyme gene polymorphism and the
risk of ischemic heart disease. N Engl J Med 1995;
332: 706-11. Ludwig E, Comeli PS,
Anderson JL, Marenberg ME, Risch N, Berkman LF, Floderus B, de
Faire U. Genetic susceptibility to death from coronary heart disease in a
study of twins. N Engl J Med 1994; 330:
1041-6. Mattei MG, Hubert C, Alhenc-Gelas
F, Roeckel N, Corvol P, Soubrier F. Angiotensin
I-converting enzyme gene is on chromosome 17. Cytogenet
Cell Genet 1989; 51: 1041. Miller SA, Dykes DD, Polesky
HF. A simple salting out procedure for extraction Rigat B, Hubert C, Corvol P, Soubrier F. Samani NJ, Thompson JR, O’Toole L, Channer
K, Woods KL. A meta analysis of the association of the deletion allele of the
angiotensin-converting enzyme gene with myocardial
infarction. Circulation 1996; 94: 708- 12. Schuster H, Wienker TF, Stremler U, Noll B, Steinmetz A, Luft
FC. An angiotensin-converting enzyme gene variant
is associated with acute myocardial infarction. Am J Cardiol
1995; 76: 601-03. Tiret L, Rigat B, Visvikis S, et al. Evidence, from combined segregation
and linkage analysis, that a variant of the angiotensin
I-converting enzyme (ACE) gene controls plasma ACE levels. Am
J Hum Genet 1992; 51: 197-205. |